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ABSTRACT 
S100A4 belongs to the family of calcium-binding S100 proteins and modulates cell proliferation, 
cytoskeletal rearrangement, cell motility, and angiogenesis. Increased levels of S100A4 expression 
correlate with high incidence of metastasis of cancers. Up-regulation of S100A4 protein is 
demonstrated in synovial tissue and in plasma of rheumatoid arthritis (RA) patients compared with 
osteoarthritis, and the elevated expression of S100A4 is associated with increased disease activity in 
patients with RA. Dichloroacetate (DCA) was shown to have a potent anti-tumour effect by 
facilitating apoptosis and inhibiting proliferation. The aims of this thesis are to investigate 
contributions of S100A4 in experimental models of septic arthritis and antigen-induced arthritis, and 
in bone formation using S100A4KO mice. In addition, we also aim to find out the impact of DCA on 
collagen type II-induced arthritis.  
 
Our studies showed that S100A4 deficiency resulted in reduced joint inflammation and 
cartilage/bone destruction in both septic and antigen-induced arthritis in mice. Additionally, in 
septic arthritis, S100A4KO mice had less bone loss and showed a lower bacterial load in the kidneys. 
S100A4 deficiency resulted in changed pattern of adhesion molecules. In antigen-induced arthritis, 
S100A4 deficiency resulted in reduced intensity of arthritis and significantly lower frequency of bone 
destruction, supported by fewer numbers of CD4+ T cells and CD19+CD5+ B cells accumulated in 
synovia and spleen compared with WT mice. Smaller populations of CD4+ and CD8+ T cells in 
spleen of S100A4 deficient mice were accompanied by reduced productions of INF-γ and IL-17A, 
and lower expression of Th17 transcription factor RORγt. Difference in the severity of arthritis was 
observed in female mice in septic arthritis and in male mice in antigen-induced arthritis. To assess the 
role of sex hormone on bone, we analysed BMD in S100A4KO and WT mice. S100A4KO mice had 
higher total BMD and female mice displayed more cortical bone content compared with WT mice. 
Following ovariectomy (OVX), both S100A4KO and WT mice lost BMD. However, cortical bone loss 
was more pronounced in S100A4KO mice than in WT supported by high CTX-I level. The loss of 
trabecular bone was similar in S100A4KO and WT mice. DHEA treatment resulted in a significant 
increase in the trabecular and cortical BMD both in WT and S100A4KO mice. This increase of BMD 
was lower in S100A4KO mice. The collagen-type II arthritis model was employed to study the 
potential effect of dichloroacetate (DCA) treatment on experimental arthritis. Our results showed 
that mice treated with DCA had a slower onset of CIA, and significantly lower severity and frequency 
of joint inflammation and cartilage/bone destruction compared with water-treated controls. 
Moreover, DCA prevented arthritis-induced loss of cortical mineral density. The beneficial effect of 
DCA was present only in female DBA/1 mice. DCA treatment on the OVX mice did not protect from 
the development of arthritis, indicating that effect of DCA is potentially estrogen-dependent.  
 
In conclusion, our studies demonstrate that S100A4 plays an important role in inflammation and 
bone metabolism in experimental arthritis. S100A4 deficiency protects against inflammation and 
cartilage/bone destruction in staphylococcal and antigen-induced arthritis by changing the 
expression of adhesion molecules, affecting lymphocyte maturation and functions. S100A4 is a 
regulator of bone formation in both estrogen sufficient and deficient mice. Our studies indicate that 
S100A4 protein can be a therapeutic target in arthritis and osteoporosis. We also demonstrate that 
DCA can be a potential anti-arthritis drug for female patients with RA.  
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